ATE71094T1 - 2-nitroimidazol-derivate, verwendbar als ''radiosensitizers'' fuer hypoxische tumorzellen. - Google Patents

2-nitroimidazol-derivate, verwendbar als ''radiosensitizers'' fuer hypoxische tumorzellen.

Info

Publication number
ATE71094T1
ATE71094T1 AT88112377T AT88112377T ATE71094T1 AT E71094 T1 ATE71094 T1 AT E71094T1 AT 88112377 T AT88112377 T AT 88112377T AT 88112377 T AT88112377 T AT 88112377T AT E71094 T1 ATE71094 T1 AT E71094T1
Authority
AT
Austria
Prior art keywords
radiosensizers
usable
tumor cells
hypoxic tumor
nitroimidazole derivatives
Prior art date
Application number
AT88112377T
Other languages
German (de)
English (en)
Inventor
Mark James Suto
Leslie Morton Werbel
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE71094T1 publication Critical patent/ATE71094T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT88112377T 1987-07-31 1988-07-29 2-nitroimidazol-derivate, verwendbar als ''radiosensitizers'' fuer hypoxische tumorzellen. ATE71094T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/080,280 US4797397A (en) 1987-07-31 1987-07-31 2-nitroimidazole derivatives useful as radiosensitizers for hypoxic tumor cells
EP88112377A EP0302416B1 (en) 1987-07-31 1988-07-29 2-nitroimidazole derivatives useful as radiosensitizers for hypoxic tumor cells

Publications (1)

Publication Number Publication Date
ATE71094T1 true ATE71094T1 (de) 1992-01-15

Family

ID=22156378

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88112377T ATE71094T1 (de) 1987-07-31 1988-07-29 2-nitroimidazol-derivate, verwendbar als ''radiosensitizers'' fuer hypoxische tumorzellen.

Country Status (7)

Country Link
US (1) US4797397A (enExample)
EP (1) EP0302416B1 (enExample)
JP (1) JPS6463576A (enExample)
AT (1) ATE71094T1 (enExample)
DE (1) DE3867368D1 (enExample)
ES (1) ES2038724T3 (enExample)
GR (1) GR3003503T3 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8728418D0 (en) * 1987-12-04 1988-01-13 Jenkins T C Nitro-substituted aromatic/hetero-aromatic compounds for use in cancer treatment
US5036089A (en) * 1988-11-25 1991-07-30 Warner-Lambert Company 2-oxazolidinone derivatives of nitroimidazoles and pharmaceutical compositions useful as sensitizing agents
US5036096A (en) * 1988-11-25 1991-07-30 Warner-Lambert Company Aziridino derivatives of nitroimidazoles and pharmaceutical compositions of selected derivatives
US5073639A (en) * 1988-11-25 1991-12-17 Warner-Lambert Company Process for the synthesis of novel and known nitroimidazoles which are useful as sensitizing agents
US4954515A (en) * 1988-11-25 1990-09-04 Warner-Lambert Company Haloalkylaminomethyl-2-nitro-1H-imidazoles
GB9113487D0 (en) * 1991-06-21 1991-08-07 Amersham Int Plc Agents for hypoxic cells
USD338756S (en) 1992-03-24 1993-08-24 The Toro Company Compost bin
US5432088A (en) * 1992-03-24 1995-07-11 The Toro Company Method and apparatus for aerobic composting
EP0669913B1 (en) * 1992-11-19 2003-03-05 The Trustees Of The University Of Pennsylvania Detection of hypoxia
US6252087B1 (en) 1992-11-19 2001-06-26 The Trustees Of The University Of Pennsylvania Nitroaromatic compounds for the detection of hypoxia
US6855828B1 (en) 1992-11-19 2005-02-15 The Trustees Of The University Of Pennsylvania Detection of hypoxia
US5674693A (en) * 1994-03-18 1997-10-07 Natural Pharmacia International Inc. Derivatives of 2-nitro-imidazoles as hypoxic cell markers
US6060604A (en) * 1995-03-31 2000-05-09 Florida State University Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
US20050026974A1 (en) * 1996-02-08 2005-02-03 Trustees Of The University Of Pennsylvania Detection of hypoxia
RU2136628C1 (ru) * 1997-10-28 1999-09-10 Государственный научный центр Российской Федерации Всероссийский научно-исследовательский институт неорганических материалов им.акад.А.А.Бочвара СПОСОБ ПОЛУЧЕНИЯ ПОРОШКОВ СВЕРХПРОВОДЯЩЕЙ КЕРАМИКИ Bi - Pb - Sr - Ca - Cu - O
US20040225077A1 (en) 2002-12-30 2004-11-11 Angiotech International Ag Drug delivery from rapid gelling polymer composition
CA2514841A1 (en) * 2003-02-02 2004-08-19 Palo Alto Institute Of Molecular Medicine Cell-killing molecules and methods of use thereof
US20040202694A1 (en) * 2003-04-11 2004-10-14 Vascular Control Systems, Inc. Embolic occlusion of uterine arteries
US7608612B2 (en) 2005-01-21 2009-10-27 Richard H. Matthews Radiosensitizer formulations and methods for use
US7875602B2 (en) * 2005-10-21 2011-01-25 Sutter West Bay Hospitals Camptothecin derivatives as chemoradiosensitizing agents
US9056136B2 (en) * 2006-10-06 2015-06-16 Natural Pharmacia International, Inc. Weakly basic 2-nitroimidazoles for the non-invasive detection of tissue hypoxia
US7842278B2 (en) 2006-10-27 2010-11-30 Natural Pharmacia International, Inc. Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof
WO2008090732A1 (ja) 2007-01-26 2008-07-31 Pola Pharma Inc. 医薬組成物
WO2011109387A1 (en) * 2010-03-01 2011-09-09 Intraop Medical Corporation Radiotherapy combined with hypoxic cell sensitizers
KR101466511B1 (ko) * 2012-11-12 2014-11-27 성균관대학교산학협력단 저산소증 관련 질환의 진단 및 치료용 저산소 감응형 나노입자

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45511B1 (en) * 1976-09-01 1982-09-08 Ciba Geigy Ag New derivatives of perhydro-aza-heterocycles and processesfor the production thereof
IE47132B1 (en) * 1977-08-19 1983-12-28 Roche Products Ltd Novel nitroimidazoles and pharmaceutical preparations containing these as well as their manufacture
US4282232A (en) * 1979-04-26 1981-08-04 Research Corporation Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof
JPH0649697B2 (ja) * 1982-05-27 1994-06-29 ブリティッシュ・テクノロジー・グループ・リミテッド 放射線治療または化学療法に有用な化合物

Also Published As

Publication number Publication date
EP0302416A1 (en) 1989-02-08
JPS6463576A (en) 1989-03-09
US4797397A (en) 1989-01-10
DE3867368D1 (de) 1992-02-13
ES2038724T3 (es) 1993-08-01
EP0302416B1 (en) 1992-01-02
GR3003503T3 (enExample) 1993-03-16

Similar Documents

Publication Publication Date Title
ATE71094T1 (de) 2-nitroimidazol-derivate, verwendbar als ''radiosensitizers'' fuer hypoxische tumorzellen.
ZA881184B (en) Interstitial administration of perfluorochemical emulsions for reoxygenation of hypoxic tumor cells
SE8701933D0 (sv) Tetrahydronaphthalinderivate
HU906493D0 (en) Process for producing substituted 1,2,4-triazole derivatives and pharmaceutical preparatives containing these compounds
DK233586A (da) 5-substituerede 1,3-thiazolidon-2,4-dion forbindelser og farmaceutiske praeparater indeholdende disse
NO172344C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte flavonoidforbindelser og salter
NO891232L (no) Arylhydrazoner.
DE68920656D1 (de) Verwendung vpn Adenosin-5'-phosphate in der Behandlung von Krebscachexia.
DE68917485D1 (de) Pyridazinon-Derivate und diese enthaltende pharmazeutische Zubereitungen.
FI852806A0 (fi) 2-substituerade -1,3-propylidendifosfonatderivat och deras framstaellning.
DK465488A (da) Farmaceutisk praeparat indeholdende en triazol-forbindelse
DE3688721D1 (de) Verwendung von porphyrinderivaten bei der entdeckung und behandlung von tumoren.
SE8404283L (sv) Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
HU9303009D0 (en) New 2-saccharinyl-methyl-aryl-carboxylat derivatives and pharmaceutical preparations containing said compounds
FI853389L (fi) Tumoerlaekemedel och foerfarande foer dess framstaellning.
JPS5566547A (en) Alkene derivative*its manufacture and medicine containing it and having sexial excitement control activity
SE8602524D0 (sv) Novel quinoline derivatives, pharmaceutical compositions containing them and process for the preparation thereof
GR1000238B (el) Μεθοδος παρασκευης 3-(2-αλογονοαιθυλο)-1,4-οξαθειινων και 2-(2-αλογονοαιθυλο)-1,4-διθειινων.
SU1154907A1 (ru) Дигидрохлорид 3-(2-диэтиламиноэтилтио)-5-(2-морфолиноэтил)-1,2,4-триазино(5,6-в)индола, обладающий стресспротективной активностью
GB2185254A (en) Benzamide and nicotinamide radiosensitizers
DK223090D0 (da) Anvendelse af 1,2,4-benzotriazinoxider som straalingssensibiliserende midler og selektive cytotoksiske midler
ES8708226A1 (es) Procedimiento para la produccion de derivados de 1,4-dihi- dropiridina
SU976666A1 (ru) 2,3-дифенилтиазоло /3',2',2,3/-1,2,4-триазино-/5,6-b/ индол, обладающий противовоспалительной активностью
SU993624A1 (ru) 2,3-дифенилтиазоло (3',2',2,3)(1,2,4)триазино (6,5-в) индол, обладающий противовоспалительной активностью
DE69501810D1 (de) Verwendung von 5-Thia-1,4-Diazabicyclo [4.2.0] Octane-3,8-dioxo Verbindungen in der Antitumor-Therapie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee